GeoVax Labs, Inc. is raising $5.0 million through a direct offering for working capital

From GlobeNewswire: 2024-08-28 20:59:00

GeoVax Labs, Inc. announces a registered direct offering of 975,610 shares of common stock at $5.125 per share. Concurrently, warrants to purchase up to 975,610 shares will be issued. The offering, led by Roth Capital Partners, is expected to generate approximately $5.0 million for working capital and corporate purposes. The closing is set for August 30, 2024. Investors can access electronic copies of the offering details through the SEC’s website or Roth Capital Partners. GeoVax focuses on developing vaccines for infectious diseases like COVID-19 and oncology treatments, with a lead clinical program in COVID-19 vaccine development and oncolytic gene-directed therapy.



Read more at GlobeNewswire: GeoVax to Raise Approximately $5.0 Million of Gross